These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33837785)

  • 1. Yeasts as a promising delivery platform for DNA and RNA vaccines.
    Silva AJD; de Macêdo LS; Leal LRS; de Jesus ALS; Freitas AC
    FEMS Yeast Res; 2021 Apr; 21(3):. PubMed ID: 33837785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomedical applications of yeast- a patent view, part one: yeasts as workhorses for the production of therapeutics and vaccines.
    Roohvand F; Shokri M; Abdollahpour-Alitappeh M; Ehsani P
    Expert Opin Ther Pat; 2017 Aug; 27(8):929-951. PubMed ID: 28608761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yeast-based vaccines: New perspective in vaccine development and application.
    Kumar R; Kumar P
    FEMS Yeast Res; 2019 Mar; 19(2):. PubMed ID: 30668686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA Vaccines: Yeast as a Novel Antigen Vehicle.
    Silva AJD; de Sousa MMG; de Macêdo LS; de França Neto PL; de Moura IA; Espinoza BCF; Invenção MDCV; de Pinho SS; da Gama MATM; de Freitas AC
    Vaccines (Basel); 2023 Aug; 11(8):. PubMed ID: 37631902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal vaccines based on orally presented yeast recombinants.
    Shin MK; Yoo HS
    Vaccine; 2013 Sep; 31(40):4287-92. PubMed ID: 23891501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant protein subunit vaccine synthesis in microbes: a role for yeast?
    Bill RM
    J Pharm Pharmacol; 2015 Mar; 67(3):319-28. PubMed ID: 25556638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene delivery to dendritic cells by orally administered recombinant Saccharomyces cerevisiae in mice.
    Kiflmariam MG; Yang H; Zhang Z
    Vaccine; 2013 Feb; 31(10):1360-3. PubMed ID: 23200937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which yeast species shall I choose? Saccharomyces cerevisiae versus Pichia pastoris (review).
    Darby RA; Cartwright SP; Dilworth MV; Bill RM
    Methods Mol Biol; 2012; 866():11-23. PubMed ID: 22454110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in systems and synthetic biology approaches for developing novel cell-factories in non-conventional yeasts.
    Patra P; Das M; Kundu P; Ghosh A
    Biotechnol Adv; 2021; 47():107695. PubMed ID: 33465474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial ghosts as carriers of protein subunit and DNA-encoded antigens for vaccine applications.
    Muhammad A; Champeimont J; Mayr UB; Lubitz W; Kudela P
    Expert Rev Vaccines; 2012 Jan; 11(1):97-116. PubMed ID: 22149712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Vaccines, Adjuvants, and Delivery Systems.
    Paston SJ; Brentville VA; Symonds P; Durrant LG
    Front Immunol; 2021; 12():627932. PubMed ID: 33859638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of various yeast genera by antigen-presenting cells and influence of subcellular antigen localization on the activation of ovalbumin-specific CD8 T lymphocytes.
    Bazan SB; Geginat G; Breinig T; Schmitt MJ; Breinig F
    Vaccine; 2011 Oct; 29(45):8165-73. PubMed ID: 21856351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic biology and molecular genetics in non-conventional yeasts: Current tools and future advances.
    Wagner JM; Alper HS
    Fungal Genet Biol; 2016 Apr; 89():126-136. PubMed ID: 26701310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines.
    Liljeqvist S; Ståhl S
    J Biotechnol; 1999 Jul; 73(1):1-33. PubMed ID: 10483112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of vaccine efficacy for different antigen delivery systems for infectious pancreatic necrosis virus vaccines in Atlantic salmon (Salmo salar L.) in a cohabitation challenge model.
    Munang'andu HM; Fredriksen BN; Mutoloki S; Brudeseth B; Kuo TY; Marjara IS; Dalmo RA; Evensen Ø
    Vaccine; 2012 Jun; 30(27):4007-16. PubMed ID: 22537985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subunit vaccines based on recombinant yeast protect against influenza A virus in a one-shot vaccination scheme.
    Gebauer M; Hürlimann HC; Behrens M; Wolff T; Behrens SE
    Vaccine; 2019 Sep; 37(37):5578-5587. PubMed ID: 31399274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors.
    Walcher P; Mayr UB; Azimpour-Tabrizi C; Eko FO; Jechlinger W; Mayrhofer P; Alefantis T; Mujer CV; DelVecchio VG; Lubitz W
    Expert Rev Vaccines; 2004 Dec; 3(6):681-91. PubMed ID: 15606353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yeast as carrier for drug delivery and vaccine construction.
    Tan Y; Chen L; Li K; Lou B; Liu Y; Liu Z
    J Control Release; 2022 Jun; 346():358-379. PubMed ID: 35483637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity against CyHV-3 infection via different prime-boost vaccination regimens using CyHV-3 ORF131-based DNA/protein subunit vaccines in carp Cyprinus carpio var. Jian.
    Liu Z; Wu J; Ma Y; Hao L; Liang Z; Ma J; Ke H; Li Y; Cao J
    Fish Shellfish Immunol; 2020 Mar; 98():342-353. PubMed ID: 31978531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis.
    West NP; Thomson SA; Triccas JA; Medveczky CJ; Ramshaw IA; Britton WJ
    Vaccine; 2011 Oct; 29(44):7759-65. PubMed ID: 21846485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.